Jefferies Maintains a 'Hold' on Blackbaud (BLKB); Loud Qtr/Guidance...Underlying Trends Look Decent
Get Alerts BLKB Hot Sheet
Price: $46.45 +0.63%
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Jefferies maintains a 'Hold' on Blackbaud (NASDAQ: BLKB) price target raised $1 to $28.
Analyst, Ross MacMillan, said, "Underlying trends at BLKB appear decent, but 4Q11 contained one-time revenue and cost adjustments plus prior-period restatements. There are cost (and minimal rev) impacts in CY12, which depress op margin, but 10%+ organic growth, transition to subscription and LT OM expanson remain intact."
Jefferies lowers FY12 EPS estimate from $1.19 to $1.15 and raises FY13 from $1.35 to $1.42.
For an analyst ratings summary and ratings history on Blackbaud click here. For more ratings news on Blackbaud click here.
Shares of Blackbaud closed at $32.00 yesterday.
Analyst, Ross MacMillan, said, "Underlying trends at BLKB appear decent, but 4Q11 contained one-time revenue and cost adjustments plus prior-period restatements. There are cost (and minimal rev) impacts in CY12, which depress op margin, but 10%+ organic growth, transition to subscription and LT OM expanson remain intact."
Jefferies lowers FY12 EPS estimate from $1.19 to $1.15 and raises FY13 from $1.35 to $1.42.
For an analyst ratings summary and ratings history on Blackbaud click here. For more ratings news on Blackbaud click here.
Shares of Blackbaud closed at $32.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share